Onconetix, Inc. Operating Lease, Liability, Noncurrent
Onconetix, Inc. (ONCO) had Operating Lease, Liability, Noncurrent of $12.31 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-13
- 2026-06-30: Operating Lease, Liability, Noncurrent $12.31K.
- 2026-03-31: Operating Lease, Liability, Noncurrent $18.31K.
- 2025-12-31: Operating Lease, Liability, Noncurrent $24.36K.
- 2024-09-30: Operating Lease, Liability, Noncurrent $32.28K.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $12.31K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $18.31K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $24.36K 10-Q · filed 2026-08-13 |
| 2024-09-30 | $32.28K 10-Q · filed 2024-12-10 |
| 2024-06-30 | $60.51K 10-Q · filed 2024-08-29 |
| 2024-03-31 | $46.88K 10-Q · filed 2024-05-20 |
| 2023-12-31 | $74.29K 10-K · filed 2025-06-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |